CIK 0001815442 · Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812992166
- Phone
- 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-25 | Goodman Noah Chief Business Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 90,000 | ||
| 2026-06-24 | Booth Bruce Director | Sale 10b5-1 | −103,688 | $100.42 | $10.4M | 3,357,833 |
| 2026-06-24 | Booth Bruce Director | Sale 10b5-1 | −14,513 | $100.42 | $1.5M | 599,076 |
| 2026-06-24 | Booth Bruce Director | Sale 10b5-1 | −14,490 | $101.14 | $1.5M | 3,343,343 |
| 2026-06-24 | Booth Bruce Director | Sale 10b5-1 | −2,029 | $101.14 | $205K | 597,047 |
| 2026-06-24 | Booth Bruce Director | Grant or award · Stock Option (Right to Buy) | +6,068 | 6,068 | ||
| 2026-06-24 | Hrustanovic Gorjan Director | Grant or award · Stock Option (Right to Buy) | +6,068 | 6,068 | ||
| 2026-06-24 | Ridloff Elena Director | Grant or award · Stock Option (Right to Buy) | +6,068 | 6,068 | ||
| 2026-06-24 | MARAGANORE JOHN Director | Grant or award · Stock Option (Right to Buy) | +6,068 | 6,068 | ||
| 2026-06-24 | Albers Jeffrey W. Director | Grant or award · Stock Option (Right to Buy) | +6,068 | 6,068 | ||
| 2026-06-24 | Sandor Victor Director | Grant or award · Stock Option (Right to Buy) | +6,068 | 6,068 | ||
| 2026-06-24 | Esposito Pamela Director | Grant or award · Stock Option (Right to Buy) | +6,068 | 6,068 | ||
| 2026-06-24 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy) | +6,068 | 6,068 | ||
| 2026-06-24 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy) | +6,068 | 6,068 | ||
| 2026-06-24 | BVF PARTNERS L P/IL Director | Grant or award · Stock Option (Right to Buy) | +6,068 | 6,068 | ||
| 2026-06-23 | Booth Bruce Director | Sale 10b5-1 | −1,235 | $99.98 | $123K | 3,461,521 |
| 2026-06-23 | Booth Bruce Director | Sale 10b5-1 | −173 | $99.98 | $17K | 613,589 |
| 2026-06-22 | Booth Bruce Director | Sale 10b5-1 | −18,313 | $103.42 | $1.9M | 3,472,340 |
| 2026-06-22 | Booth Bruce Director | Sale 10b5-1 | −9,584 | $104.38 | $1.0M | 3,462,756 |
| 2026-06-22 | Booth Bruce Director | Sale 10b5-1 | −2,560 | $103.42 | $265K | 615,103 |
Page 8 of 25 · 493 trades